Biotech entity

Mindray

Company

Every one of those 1 sits in a single category, pharma. Mindray is most often covered alongside GE Healthcare, which appears in 1 of these 1 story. Mindray appears in 1 tracked Biotech story from March 10, 2026. The tracked stories average 2 original sources each.

Last mentioned: Mar 10, 2026

Entity pulse

Recent coverage · Mindray

1 story
7 avg impact
0% positive
100% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.

  • 100% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Mindray

Every one of those 1 sits in a single category, pharma. Mindray is most often covered alongside GE Healthcare, which appears in 1 of these 1 story. Mindray appears in 1 tracked Biotech story from March 10, 2026. The tracked stories average 2 original sources each.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 19 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Mindray. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Initial Audit Completion

    First round of device assessments expected to be finalized.

  2. Audit Framework Development

    State agencies begin defining security criteria for medical hardware.

  3. Executive Order Issued

    Governor Abbott mandates cybersecurity audits for Chinese medical devices.

Stories mentioning Mindray 1

Pharma Negative

Texas Orders Cybersecurity Audit of Chinese Medical Devices Over Data Risks

Texas Governor Greg Abbott has mandated a comprehensive cybersecurity audit of Chinese-manufactured medical devices used in state facilities, citing national security and data privacy risks. The move signals a growing trend of state-level intervention in the healthcare supply chain, mirroring federal efforts to decouple from Chinese biotechnology and hardware.

2 sources

Mindray is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.